You have 9 free searches left this month | for more free features.

Ghrelin

Showing 1 - 25 of 1,111

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Ghrelin and Diastolic Heart Function

Completed
  • Diabetes Mellitus, Type 2
  • +2 more
  • abdominal plastic intervention
  • Naples, Italy
    Celestino Sardu
Aug 4, 2023

Fetal Growth Retardation After Sleeve Gastrectomy: Involvement

Recruiting
  • In Utero Growth Retardation
  • +2 more
    • Colombes, France
      Hopital Louis Mourier
    Aug 3, 2023

    Obesity Trial in Nashville (Oral Glucose Tolerance Test (OGTT), Human Ghrelin, Saline)

    Active, not recruiting
    • Obesity
    • Oral Glucose Tolerance Test (OGTT)
    • +2 more
    • Nashville, Tennessee
      Vanderbilt University Medical Center
    Nov 18, 2022

    Stroke, Ischemic Trial in Enschede, Utrecht, Zwolle (Ghrelin)

    Not yet recruiting
    • Stroke, Ischemic
    • Ghrelin
    • Enschede, Netherlands
    • +2 more
    Feb 1, 2023

    Bariatric Surgery Trial in Copenhagen (Placebo, Ghrelin)

    Recruiting
    • Bariatric Surgery
    • Placebo
    • Ghrelin
    • Copenhagen, Hvidovre, Denmark
      Department of Endocrinology, Hvidovre University Hospital
    Aug 15, 2022

    Dementia Trial in Swansea (Venous blood collection)

    Recruiting
    • Dementia
    • Venous blood collection
    • Swansea, United Kingdom
      Swansea University
    Sep 8, 2022

    MDD Trial in Tübingen (Ghrelin, Placebo)

    Recruiting
    • Major Depressive Disorder
    • Ghrelin
    • Placebo
    • Tübingen, BW, Germany
      Department of Psychiatry & Psychotherapy, University of Tübingen
    Apr 7, 2022

    Bariatric Surgery Candidate, Glucose Metabolism Disorders Trial in Hvidovre (Ghrelin, Placebo)

    Recruiting
    • Bariatric Surgery Candidate
    • Glucose Metabolism Disorders
    • Ghrelin
    • Placebo
    • Hvidovre, Denmark
      Hvidovre Universitets Hospital
    Feb 3, 2022

    Obesity, Insulin Resistance, Cardiovascular Risk Factor Trial in Charlottesville (Exercise)

    Recruiting
    • Obesity
    • +2 more
    • Exercise
    • Charlottesville, Virginia
      University of Virginia
    May 13, 2022

    Concussion, Brain, Traumatic Brain Injury Trial in Kansas City (Ghrelin (OXE-103), Placebo)

    Recruiting
    • Concussion, Brain
    • Traumatic Brain Injury
    • Ghrelin (OXE-103)
    • Placebo
    • Kansas City, Kansas
      University of Kansas Medical Center
    Jan 7, 2022

    Eating Disorder, Bulimia Nervosa Trial (Acipimox, Placebo)

    Enrolling by invitation
    • Eating Disorder
    • Bulimia Nervosa
    • (no location specified)
    Jul 19, 2022

    Binge Eating Disorder Trial in Alexandria (behavioral, drug, diagnostic test)

    Recruiting
    • Binge Eating Disorder
    • DBT
    • +2 more
    • Alexandria, Egypt
      Faculty of Medicine, Alexandria University
    Oct 1, 2022

    Sarcopenia, Osteopenia Trial in Boston (Anamorelin Hydrochloride, Placebo)

    Active, not recruiting
    • Sarcopenia
    • Osteopenia
    • Anamorelin Hydrochloride
    • Placebo
    • Boston, Massachusetts
      Jean Mayer USDA Human Nutrition Research Center on Aging at Tuft
    Feb 4, 2022

    Peripheral Artery Disease Trial in Chicago (Ghrelin, Placebo)

    Recruiting
    • Peripheral Artery Disease
    • Ghrelin
    • Placebo
    • Chicago, Illinois
    • +1 more
    Aug 10, 2021

    Metabolic Syndrome, Menopause, Cardiovascular Diseases Trial in Swansea (Exercise Only (Ex only), Exercise and Mediterranean

    Recruiting
    • Metabolic Syndrome
    • +4 more
    • Exercise Only (Ex only)
    • Exercise and Mediterranean Diet (Ex + MedDiet)
    • Swansea, United Kingdom
      Swansea University
    Sep 8, 2022

    Heart Failure With Reduced Ejection Fraction HFrEF Trial (Ghrelin, Placebo)

    Completed
    • Heart Failure With Reduced Ejection Fraction HFrEF
    • Ghrelin
    • Placebo
    • (no location specified)
    Mar 11, 2022

    Angelman Syndrome, Smith-Magenis Syndrome, X Fragile Syndrome Trial (acylated and unacylated ghrelin dosages)

    Not yet recruiting
    • Angelman Syndrome
    • +4 more
    • acylated and unacylated ghrelin dosages
    • (no location specified)
    Feb 23, 2021

    Ghrelin Trial in Yangsan (Combined exercise program, Control)

    Completed
    • Ghrelin
    • Combined exercise program
    • Control
    • Yangsan, Gyeungsangnam-do, Korea, Republic of
      Pusan National University Yangsan Hospital
    Jun 24, 2020

    Healthy Volunteers, Obesity Trial in Durham (Ghrelin, Saline)

    Withdrawn
    • Healthy Volunteers
    • Obesity
    • Durham, North Carolina
      Duke Sociology-Psychology Building 417 Chapel Drive
    Jan 23, 2020

    Peripheral Artery Disease, PAD, Peripheral Arterial Disease Trial in Chicago (unacelyated ghrelin)

    Completed
    • Peripheral Artery Disease
    • +2 more
    • unacelyated ghrelin
    • Chicago, Illinois
      Northwestern University Feinberg School of Medicine
    Feb 26, 2020

    Obesity, Bariatric Surgery Candidate, Appetitive Behavior Trial in London (GLWL-01, Placebo)

    Completed
    • Obesity
    • +2 more
    • London, United Kingdom
      University College London
    May 18, 2020

    Weight Loss, Adolescent Obesity Trial in Semarang (Modification Lifesyle)

    Completed
    • Weight Loss
    • Adolescent Obesity
    • Modification Lifesyle
    • Semarang, Central Java, Indonesia
      Etika Ratna Noer
    Jun 11, 2020

    The Frailty Syndrome Trial in Philadelphia (Ghrelin Group 1, Ghrelin Group 2)

    Completed
    • The Frailty Syndrome
    • Ghrelin Group 1
    • Ghrelin Group 2
    • Philadelphia, Pennsylvania
      Clinical and Translational Research Center, University of Pennsy
    Nov 26, 2019

    Frailty Syndrome Trial in Philadelphia (Ghrelin, Placebo)

    Completed
    • Frailty Syndrome
    • Ghrelin
    • Placebo
    • Philadelphia, Pennsylvania
      Clinical and Translational Research Center, University of Pennsy
    Nov 26, 2019

    Obesity, Smoking Cessation, Alcoholism Trial in London (Exenatide, Desacyl ghrelin, Saline)

    Unknown status
    • Obesity
    • +2 more
    • London, United Kingdom
      Centre for Neuropsychopharmacology, Division of Brain Sciences,
    Feb 11, 2020